Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 10064680.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Symptoms and laboratory evidence of adrenal suppression developed in 2 children with the human immunodeficiency virus after megestrol acetate (MA) therapy was discontinued; both required transient glucocorticoid replacement therapy. High-dose corticotropin stimulation testing performed on children with the human immunodeficiency virus treated or not treated with MA showed that baseline and post-corticotropin cortisol levels were extremely low in 7 of 10 treated patients and normal in 10 of 10 members of a control group (P <.01). MA may suppress adrenal function, and replacement glucocorticoids may prevent or relieve associated symptoms at times of severe stress or on discontinuation of MA therapy.
Medical subject headings
- Adrenal Insufficiency
- Appetite Stimulants
- HIV Infections
- HIV-1
- Megestrol Acetate